Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2012
Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasterideAlan R Kristal, Cathee Till, Catherine M Tangen, et al.
Toxicology and Applied Pharmacology|December 6, 2025
Ghrelin-disrupting activity of arsenic and its relation to cardiometabolic diseasesKamrun Nahar Rossi, Faysal Abedin, Nayan Chandra Mohanto, et al.
Environmental Toxicology and Pharmacology|September 26, 2025
Relationship of fractalkine with arsenic exposure and the risk of cardiovascular diseasesNesar Uddin, Rajoana Karim Rimi, Osman Goni, et al.
Toxicology and Applied Pharmacology|April 12, 2021
T helper 2-driven immune dysfunction in chronic arsenic-exposed individuals and its link to the features of allergic asthmaAtiqur Rahman, Md Shofikul Islam, Selim Reza Tony, et al.
Cancer Causes & Control : CCC|June 14, 2011
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control studySong Yao, Cathee Till, Alan R Kristal, et al.
Journal of the National Cancer Institute|January 20, 2005
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Scott M Lippman, Phyllis J Goodman, Eric A Klein, et al.
Clinical and Experimental Immunology|April 20, 2024
Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recoveryMohammad Ali, Stephanie Longet, Isabel Neale, et al.
The American Journal of Surgical Pathology|September 27, 2006
A working group classification of focal prostate atrophy lesionsAngelo M De Marzo, Elizabeth A Platz, Jonathan I Epstein, et al.
Pageof 8